| Summary: | George Worthen,1 Karthik Tennankore2 1Department of Medicine, Nova Scotia Health Authority, Halifax, NS, Canada; 2Division of Nephrology, Nova Scotia Health Authority, Halifax, NS, CanadaCorrespondence: Karthik TennankoreDivision of Nephrology, QEII - Dickson Building, Suite 5090 Dickson Building, 5820 University Avenue, Halifax, NS B3H 2Y9, CanadaTel +1 902-473-2099Fax +1 902-473-2675Email KarthikK.Tennankore@nshealth.caAbstract: Frailty has been defined as a state of increased vulnerability as a consequence of deficit accumulation. Frailty screening has not yet been widely implemented into routine nephrology care. Patients with chronic kidney disease (CKD) are at high risk of being frail, and frailty has been associated with worse outcomes in this population. Standard management of CKD, including initiation of renal replacement therapies, may have decreased benefit or potentially cause harm in the presence of frailty, and a variety of interventions for modifying frailty in the CKD population have been proposed. The optimal means of screening for frailty in patients with kidney disease remains unclear. This review highlights the value of frailty screening in CKD by summarizing the outcomes associated with frailty and exploring proposed changes to the management of frail patients with CKD. Finally, we will propose a framework for how to implement frailty screening into standard nephrology care.Keywords: geriatrics, sarcopenia, transplant, dialysis, conservative management
|
|---|
